Bone mineral density in adults with the metabolic syndrome: Analysis in a population-based US sample

被引:112
作者
Kinjo, Mitsuyo
Setoguchi, Soko
Solomon, Daniel H.
机构
[1] Teine Keijinkai Hosp, Teine Ku, Sapporo, Hokkaido 0068555, Japan
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol, Boston, MA 02115 USA
关键词
D O I
10.1210/jc.2007-0757
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The metabolic syndrome is associated with low-grade inflammation. It has been suggested that proinflammatory cytokines and low-grade systemic inflammation activate bone resorption and may lead to reduced bone mineral density (BMD), but no previous studies have evaluated the association between the metabolic syndrome and BMD. We examined this relationship in a representative U. S. population-based sample from the Third National Health and Nutrition Examination Survey ( NHANES III, 1988-1994). Methods: We identified adult subjects enrolled in NHANES III with the metabolic syndrome as defined by the criteria of the Adult Treatment Panel III. We conducted a cross-sectional analysis of femoral neck BMD (FN-BMD) for subjects with and without the metabolic syndrome. Analyses were adjusted for relevant covariates and stratified by quintile of body mass index. Results: Among 8197 persons at least 20 yr old who underwent FN-BMD measurement, 1773 (22%) had the metabolic syndrome. After multivariable adjustment, FN-BMD was higher among subjects with the metabolic syndrome (0.86 g/cm(2)) than those without (0.80 g/cm(2); P < 0.0001). When stratified by body mass index, FN-BMD was similar between subjects with and without the metabolic syndrome. Adjusted FN-BMD increased with additional components of the metabolic syndrome ( P < 0.0001 for trend), and there was a significant positive association with abdominal obesity ( P < 0.0001). A subgroup of subjects with diabetes had higher FM-BMD than those without, independent of abdominal obesity. Conclusions: In NHANES III, the metabolic syndrome was not associated with reduced FN-BMD.
引用
收藏
页码:4161 / 4164
页数:4
相关论文
共 24 条
[1]   Correlations between insulin sensitivity and bone mineral density in non-diabetic men [J].
Abrahamsen, B ;
Rohold, A ;
Henriksen, JE ;
Beck-Nielsen, H .
DIABETIC MEDICINE, 2000, 17 (02) :124-129
[2]   Features of the metabolic syndrome and the risk of non-vertebral fractures: The Tromso study [J].
Ahmed, LA ;
Schirmer, H ;
Berntsen, GK ;
Fonnebo, V ;
Joakimsen, RMJ .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (03) :426-432
[3]  
[Anonymous], 1994, VITAL HLTH STAT, V1, P1
[4]  
[Anonymous], 1996, EX FIL 3 NAT HLTH NU
[5]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[6]  
Ganesan K, 2005, J NATL MED ASSOC, V97, P329
[7]   Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases [J].
Hofbauer, LC ;
Schoppet, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (04) :490-495
[8]   Role of RANKL and RANK in bone loss and arthritis [J].
Jones, DH ;
Kong, YY ;
Penninger, JM .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 :32-39
[9]   Type 2 diabetes is associated with increased bone mineral density in Mexican-American women [J].
Kao, WHL ;
Kammerer, CM ;
Schneider, JL ;
Bauer, RL ;
Mitchell, BD .
ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (05) :399-406
[10]   The management of secondary osteoporosis [J].
Kelman, A ;
Lane, NE .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (06) :1021-1037